China has 379 endemic counties with about 172,000 individuals affected by Kashin-Beck disease (KBD) by 2021, emphasizing the scale of the issue.
Current clinical interventions like surgeries, medications, and therapies for KBD are insufficient in addressing the root cause, pushing the need for more effective treatments targeting disease mechanisms.
Collection
[
|
...
]